Pancreatic Cancer Research

ResearcherCapital Medical UniversityNo recent work listed

Xinxue Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9885-6402; OpenAlex author ID A5052610879. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: 1 paper

Papers 4

  1. Effect of the preoperative prognostic nutritional index on the long-term prognosis in patients with borderline resectable pancreatic cancer after pancreaticodu… Co-author DOI 10.3389/fonc.2023.1098459↗
  2. MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer. Co-author DOI 10.1155/2022/5514715↗
  3. Prognostic Value of Preoperative NLR and Vascular Reconstructive Technology in Patients With Pancreatic Cancer of Portal System Invasion: A Real World Study. Co-author DOI 10.3389/fonc.2021.682928↗
  4. MiR-374b-5p inhibits KDM5B-induced epithelial-mesenchymal transition in pancreatic cancer. Co-author PMID 34522457↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ren Lang · 4 shared papers, 2021–2023 · strength 0.64
  2. Shaocheng Lyu · 2 shared papers, 2021–2023 · strength 0.36
  3. Xin Zhao · 2 shared papers, 2021–2022 · strength 0.28
  4. Jincan Huang · 1 shared paper, 2023 · strength 0.22
  5. Junming Xu · 1 shared paper, 2022 · strength 0.15
  6. Qiang He · 1 shared paper, 2022 · strength 0.15
  7. Qing Chen · 1 shared paper, 2022 · strength 0.15
  8. Zhangyong Ren · 1 shared paper, 2022 · strength 0.15
  9. Zhe Liu · 1 shared paper, 2022 · strength 0.15
  10. Lin Zhou · 1 shared paper, 2021 · strength 0.14
  11. Jing Wang · 1 shared paper, 2021 · strength 0.14
  12. Qiang He · 1 shared paper, 2021 · strength 0.14
  13. Li-chao Pan · 1 shared paper, 2021 · strength 0.14
  14. Qiang He · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.